APOA5 and metabolic syndrome: For APOA5 variants, a recognized player in MetS, it is believed to affect insulin resistance, systolic blood pressure, and triglyceride levels (Sandhofer et al., 2006; Xiao-Yan et al., 2013; Castellano-Castillo et al., 2018).